The rarer ‘cytokine release syndrome’ (CRS) signature found in 26% of patients showed minimal deviation in gene expression from the control group, but was marked by the proliferation of NK-T-cells, and enhanced production of cytokines such as IL1 and CCL19. This evidence concerns the gene IL1B and congenital rubella syndrome.